LM Pay

LM Pay Net Debt / EBITDA

The Net Debt to EBITDA of LM Pay (Y00.BE) as of Oct 24, 2026 is 194.18. In the previous year, Net Debt to EBITDA was 16.55 — a change of 1,073.53% (higher).

Net Debt / EBITDA

194.18

YoY

1,073.53%

Last updated:

Net Debt to EBITDA of LM Pay is 2023 194.18 . Net Debt to EBITDA of LM Pay was 2022 16.55 . It decreases by 1,073.53% higher compared to the previous year.

The LM Pay Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2021
9.19 PLN
Jan 1, 2022
16.55 PLN
Jan 1, 2023
194.18 PLN
The LM Pay Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
194.18+1,073.53%
16.55+80.14%
9.19—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LM Pay Stock analysis

What does LM Pay do? LM Pay SA generates revenue through its MediRaty financing and installment payment system, which targets consumers seeking medical and veterinary services. The company partners with clinics offering specialized treatments like dentistry, plastic surgery, and orthopedics, enabling patients to finance procedures such as dental implants, liposuction, and breast augmentation through MediRaty or MediPay programs. These services are available at both partner facilities and non-partner locations, with financing options tailored to cover costs in fields including ophthalmology, gynecology, and veterinary care. The firm monetizes by facilitating installment payments for medical and veterinary expenses without direct ownership of the services provided. The primary customers are individuals requiring medical treatments or veterinary services, with the company focusing on high-cost procedures such as orthodontic braces, implant prosthetics, and aesthetic surgeries. LM Pay SA’s revenue model relies on transaction fees from clinics and service providers that utilize its financing platforms, rather than direct consumer payments. This approach allows the company to serve a broad segment of consumers seeking accessible financing for healthcare without bearing the risk of the medical services themselves. MediRaty and MediPay programs are designed to integrate seamlessly with clinics' operations, providing patients with flexible payment options. The company’s revenue streams are derived from the financial institutions or healthcare providers that adopt its systems, as these partners pay for access to the financing infrastructure. This business model ensures consistent income from established healthcare and veterinary service providers across Poland, supporting the expansion of affordable healthcare financing options for end-users. LM Pay is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LM Pay stock

Net Debt to EBITDA of LM Pay is 194.18 in 2023.

Net Debt to EBITDA of LM Pay changed from 16.55 to 194.18, representing a 1,073.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA LM Pay since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's LM Pay with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — LM Pay

All Key Metrics — LM Pay